NYSE:WST - West Pharmaceutical Services Stock Price, Price Target & More

$91.02 -0.74 (-0.81 %)

(As of 04/20/2018 04:00 PM ET)

Previous Close$91.76

Today's Range$90.88 - $91.74

52-Week Range$80.02 - $103.36

Volume210,810 shs

Average Volume406,826 shs

Market Capitalization$6.80 billion

P/E Ratio32.74

Dividend Yield0.61%

Beta1.11

About West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified

Sub-IndustryHealth Care Supplies

SectorMedical

SymbolNYSE:WST

CUSIP95530610

Webwww.westpharma.com

Phone610-594-2900

Debt

Debt-to-Equity Ratio0.15%

Current Ratio2.66%

Quick Ratio1.89%

Price-To-Earnings

Trailing P/E Ratio32.74

Forward P/E Ratio32.05

P/E Growth2.83

Sales & Book Value

Annual Sales$1.60 billion

Price / Sales4.21

Cash Flow$4.0963 per share

Price / Cash22.22

Book Value$17.24 per share

Price / Book5.28

Profitability

EPS (Most Recent Fiscal Year)$2.78

Net Income$150.70 million

Net Margins9.42%

Return on Equity14.68%

Return on Assets9.97%

Miscellaneous

Employees7,500

Outstanding Shares73,990,000

How to Become a New Pot Stock Millionaire

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Thursday, February 15th. Stockholders of record on Wednesday, April 18th will be given a dividend of $0.14 per share on Wednesday, May 2nd. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date is Tuesday, April 17th. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services declared that its Board of Directors has initiated a share buyback plan on Thursday, February 15th 2018, which allows the company to buyback 800,000 shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services (NYSE:WST) announced its quarterly earnings data on Thursday, February, 15th. The medical instruments supplier reported $0.64 EPS for the quarter, beating the Zacks' consensus estimate of $0.62 by $0.02. The medical instruments supplier had revenue of $415.60 million for the quarter, compared to analyst estimates of $416.90 million. West Pharmaceutical Services had a return on equity of 14.68% and a net margin of 9.42%. West Pharmaceutical Services's revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted $0.54 EPS. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY18 earnings guidance on Thursday, February, 15th. The company provided earnings per share (EPS) guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.90. The company issued revenue guidance of $1.72-1.73 billion, compared to the consensus revenue estimate of $1.73 billion.

What price target have analysts set for WST?

5 Wall Street analysts have issued 1-year target prices for West Pharmaceutical Services' shares. Their predictions range from $98.00 to $115.00. On average, they expect West Pharmaceutical Services' share price to reach $106.80 in the next twelve months. View Analyst Ratings for West Pharmaceutical Services.

Who are some of West Pharmaceutical Services' key competitors?

Some companies that are related to West Pharmaceutical Services include Ipsen (IPSEY), Olympus (OCPNY), Genmab As (GNMSF), Ramsay Health Care (RHC), Teleflex (TFX), Aegon (AGN), Davita (DVA), Perrigo (PRGO), Smith & Nephew (SN), Lundbeck (HLUYY), Varian Medical Systems (VAR), Dentsply Sirona (XRAY), Universal Health Services (UHS), The Cooper Companies (COO), Henry Schein (HSIC), Hologic (HOLX), Sonova (SONVY) and William Demant (WILYY).

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:

Mr. Eric M. Green, Chief Exec. Officer, Pres and Director (Age 48)
Mr. William J. Federici, Chief Financial Officer, Sr. VP and Treasurer (Age 58)
Mr. George Lloyd Miller, Sr. VP, Gen. Counsel and Corp. Sec. (Age 63)
Ms. Annette F. Favorite, Chief HR Officer and Sr. VP (Age 53)
Ms. Karen A. Flynn, Chief Commercial Officer and Sr. VP (Age 55)

Has West Pharmaceutical Services been receiving favorable news coverage?

News headlines about WST stock have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. West Pharmaceutical Services earned a coverage optimism score of 0.24 on Accern's scale. They also assigned media stories about the medical instruments supplier an impact score of 45.29 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $91.02.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $6.80 billion and generates $1.60 billion in revenue each year. The medical instruments supplier earns $150.70 million in net income (profit) each year or $2.78 on an earnings per share basis. West Pharmaceutical Services employs 7,500 workers across the globe.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]

MarketBeat Community Rating for West Pharmaceutical Services (WST)

Community Ranking:		1.7 out of 5 ()
Outperform Votes:		124 (Vote Outperform)
Underperform Votes:		236 (Vote Underperform)
Total Votes:		360

MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.

West Pharmaceutical Services (NYSE:WST) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

5 Wall Street analysts have issued ratings and price targets for West Pharmaceutical Services in the last 12 months. Their average twelve-month price target is $106.80, suggesting that the stock has a possible upside of 17.34%. The high price target for WST is $115.00 and the low price target for WST is $98.00. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Buy	Buy
Consensus Rating Score:	2.40	2.40	2.50	2.60
Ratings Breakdown:	0 Sell Rating(s) 3 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$106.80	$106.80	$106.00	$104.00
Price Target Upside:	17.34% upside	6.40% upside	5.02% upside	8.71% upside

West Pharmaceutical Services (NYSE:WST) Consensus Price Target History

Price Target History for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
1/24/2018	Goldman Sachs	Initiated Coverage	Neutral -> Neutral	$110.00	Low
10/27/2017	Wells Fargo	Boost Price Target	Outperform	$105.00 -> $112.00	N/A
10/17/2017	Bank of America	Downgrade	Buy -> Neutral	$98.00	N/A
10/3/2017	Stephens	Initiated Coverage	Equal -> Equal Weight	$99.00	Medium
9/15/2017	Jefferies Group	Upgrade	Hold -> Buy	$96.00 -> $115.00	High
12/23/2016	Janney Montgomery Scott	Reiterated Rating	Buy		N/A

(Data available from 4/21/2016 forward)

West Pharmaceutical Services (NYSE:WST) Earnings History and Estimates Chart

Earnings by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Earnings Estimates

2018 EPS Consensus Estimate: $2.84

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.64	$0.64	$0.64
Q2 2018	1	$0.70	$0.70	$0.70
Q3 2018	1	$0.73	$0.73	$0.73
Q4 2018	1	$0.77	$0.77	$0.77

West Pharmaceutical Services (NYSE WST) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/25/2018							N/A
2/15/2018	Q4 2017	$0.62	$0.64	$416.90 million	$415.60 million	View	N/A
10/26/2017	Q3 2017	$0.53	$0.67	$386.02 million	$398.20 million	View	N/A
7/27/2017	Q2 2017	$0.65	$0.6560	$406.00 million	$397.60 million	View	N/A
4/27/2017	Q1 2017	$0.55	$0.81	$380.42 million	$387.70 million	View	N/A
2/16/2017	Q416	$0.56	$0.54	$387.31 million	$382.30 million	View	Listen
10/27/2016	Q316	$0.53	$0.53	$371.76 million	$376.70 million	View	Listen
7/28/2016	Q216	$0.56	$0.59	$384.58 million	$388.00 million	View	Listen
4/28/2016	Q116	$0.51	$0.53	$355.86 million	$362.10 million	View	Listen
2/18/2016	Q415	$0.47	$0.47	$364.76 million	$359.70 million	View	Listen
10/29/2015	Q315	$0.43	$0.44	$355.90 million	$344.50 million	View	Listen
7/30/2015	Q215	$0.45	$0.47	$356.33 million	$359.70 million	View	Listen
4/30/2015	Q115	$0.40	$0.45	$346.64 million	$335.90 million	View	Listen
2/19/2015	Q414	$0.46	$0.45	$348.33 million	$349.80 million	View	Listen
10/30/2014	Q314	$0.43	$0.44	$356.08 million	$355.90 million	View	Listen
7/31/2014	Q214	$0.47	$0.52	$368.60 million	$368.90 million	View	N/A
5/1/2014	Q114	$0.41	$0.38	$340.90 million	$346.80 million	View	Listen
2/20/2014	Q413	$0.38	$0.38	$348.70 million	$342.70 million	View	Listen
10/31/2013	Q3 13	$0.36	$0.39	$333.25 million	$341.80 million	View	Listen
8/1/2013	Q2 2013	$0.82	$0.86	$349.85 million	$344.50 million	View	Listen
5/2/2013	Q1 2013	$0.86	$0.87	$344.20 million	$339.40 million	View	Listen
2/21/2013	Q4 2012	$0.56	$0.61	$318.75 million	$321.50 million	View	Listen
11/1/2012	Q312	$0.50	$0.52	$306.91 million	$303.80 million	View	N/A
8/2/2012		$0.69	$0.79			View	N/A
4/26/2012		$0.65	$0.83			View	N/A
2/16/2012		$0.55	$0.59			View	N/A
11/1/2011		$0.54	$0.53			View	N/A
7/28/2011		$0.68	$0.62			View	N/A
4/28/2011		$0.62	$0.60			View	N/A
2/17/2011		$0.46	$0.42			View	N/A
11/2/2010	Q3 2010	$0.22	$0.23			View	N/A
8/3/2010	Q2 2010	$0.31	$0.32			View	N/A
4/29/2010	Q1 2010	$0.26	$0.29			View	N/A
2/18/2010	Q4 2009	$0.32	$0.33			View	N/A
11/3/2009	Q3 2009	$0.27	$0.23			View	N/A
8/4/2009	Q2 2009	$0.27	$0.29			View	N/A
4/30/2009	Q1 2009	$0.21	$0.21			View	N/A
2/19/2009	Q4 2008	$0.27	$0.28			View	N/A
11/4/2008	Q3 2008	$0.24	$0.19			View	N/A
8/5/2008	Q2 2008	$0.34	$0.37			View	N/A
5/1/2008	Q1 2008	$0.36	$0.36			View	N/A
2/21/2008	Q4 2007	$0.24	$0.25			View	N/A

(Earnings results data provided by Zacks Investment Research)

West Pharmaceutical Services (NYSE:WST) Dividend Information

West Pharmaceutical Services pays an annual dividend of $0.56 per share, with a dividend yield of 0.62%. WST's next quarterly dividend payment will be made on Wednesday, May 2. The company has grown its dividend for the last 25 consecutive years and is increasing its dividend by an average of 8.90% each year. West Pharmaceutical Services pays out 20.14% of its earnings out as a dividend.

Next Dividend:	5/2/2018
Annual Dividend:	$0.56
Dividend Yield:	0.62%
Dividend Growth:	8.90% (3 Year Average)
Payout Ratio:	20.14% (Trailing 12 Months of Earnings) 19.72% (Based on This Year's Estimates) 17.28% (Based on Next Year's Estimates)
Track Record:	25 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/15/2018	Quarterly	$0.14		4/17/2018	4/18/2018	5/2/2018
12/22/2017	Quarterly	$0.14	0.56%	1/17/2018	1/18/2018	2/1/2018
7/20/2017	Quarterly	$0.14	0.6%	10/17/2017	10/18/2017	11/1/2017
5/16/2017	quarterly	$0.13	0.54%	7/17/2017	7/19/2017	8/2/2017
2/16/2017	Quarterly	$0.13		4/17/2017	4/19/2017	5/3/2017
12/14/2016	quarterly	$0.13	0.61%	1/13/2017	1/18/2017	2/1/2017
9/12/2016	quarterly	$0.13		10/17/2016	10/19/2016	11/2/2016
7/6/2016	Quarterly	$0.12		7/18/2016	7/20/2016	8/3/2016
3/4/2016	Quarterly	$0.12		4/18/2016	4/20/2016	5/4/2016
12/17/2015	Quarterly	$0.12		1/15/2016	1/20/2016	2/3/2016
7/15/2015	quarterly	$0.12	0.79%	10/19/2015	10/21/2015	11/4/2015
7/2/2015	quarterly	$0.11	0.76%	7/20/2015	7/22/2015	8/5/2015
2/20/2015	quarterly	$0.11	0.82%	4/20/2015	4/22/2015	5/6/2015
12/22/2014	quarterly	$0.11	0.81%	1/16/2015	1/21/2015	2/4/2015
7/16/2014	quarterly	$0.11		10/20/2014	10/22/2014	11/5/2014
7/16/2014	quarterly	$0.11	1.11%	10/15/2014	10/19/2014	11/3/2014
5/8/2014	quarterly	$0.10	0.94%	7/21/2014	7/23/2014	8/6/2014
2/20/2014	quarterly	$0.10	0.83%	4/21/2014	4/23/2014	5/7/2014
12/19/2013	quarterly	$0.10	0.81%	1/17/2014	1/22/2014	2/5/2014
8/1/2013	quarterly	$0.20			10/23/2013	11/6/2013
5/10/2013	quarterly	$0.19	1.16%	7/22/2013	7/24/2013	8/7/2013
3/15/2013	quarterly	$0.19	1.21%	4/15/2013	4/17/2013	5/1/2013
12/27/2012	quarterly	$0.19	1.4%	1/18/2013	1/23/2013	2/6/2013

(Data available from 1/1/2013 forward)

West Pharmaceutical Services (NYSE WST) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 94.39%

Insider Trading History for West Pharmaceutical Services (NYSE:WST)

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE WST) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/8/2017	William J Federici	CFO	Sell	21,000	$99.01	$2,079,210.00	190,493
5/18/2017	William J. Federici	CFO	Sell	54,996	$95.45	$5,249,368.20
5/2/2017	Daniel Malone	VP	Sell	4,124	$93.31	$384,810.44
12/8/2016	Patrick J. Zenner	Director	Buy	332	$84.53	$28,063.96
10/31/2016	Paula A. Johnson	Director	Sell	2,466	$75.87	$187,095.42
9/6/2016	Karen Flynn	SVP	Sell	14,581	$83.28	$1,214,305.68	13,513
8/23/2016	Paula A Johnson	Director	Sell	3,042	$81.55	$248,075.10	38,450
6/2/2016	Daniel Malone	VP	Sell	3,950	$74.95	$296,052.50	30,666
5/25/2016	Thomas W Hofmann	Director	Sell	2,466	$73.57	$181,423.62	34,506
3/1/2016	Michael A Anderson	VP	Sell	16,414	$63.58	$1,043,602.12	70,507
2/29/2016	Thomas W Hofmann	Director	Sell	3,042	$62.70	$190,733.40	34,637
2/25/2016	Heino Lennartz	Insider	Sell	5,680	$62.47	$354,829.60	18,304
2/24/2016	Heino Lennartz	Insider	Sell	19,658	$59.45	$1,168,668.10	20,911
2/23/2016	Paula A. Johnson	Director	Sell	7,800	$59.39	$463,242.00
2/22/2016	Warwick Bedwell	Insider	Sell	16,042	$59.52	$954,819.84	43,623
11/25/2015	John E. Paproski	insider	Sell	17,560	$63.41	$1,113,479.60	70,288
11/12/2015	Heino Lennartz	Insider	Sell	3,500	$61.87	$216,545.00	15,435
11/6/2015	Michael A Anderson	VP	Sell	3,000	$62.18	$186,540.00	61,497
11/5/2015	Michael A. Anderson	VP	Sell	10,000	$61.98	$619,800.00	64,497
11/4/2015	Daniel Malone	VP	Sell	4,456	$61.65	$274,712.40	22,627
8/17/2015	William J Federici	CFO	Sell	52,678	$59.72	$3,145,930.16
5/28/2015	Heino Lennartz	Insider	Sell	9,584	$55.00	$527,120.00
5/22/2015	Karen Flynn	Insider	Sell	3,091	$55.24	$170,746.84
5/21/2015	Eric Mark Green	CEO	Buy	18,300	$54.89	$1,004,487.00
5/18/2015	Karen Flynn	Insider	Sell	1,909	$55.00	$104,995.00
5/15/2015	Donald E Morel Jr	CEO	Sell	20,000	$54.29	$1,085,800.00
2/27/2015	Richard D Luzzi	VP	Sell	10,000	$54.85	$548,500.00
2/26/2015	Michael A Anderson	VP	Sell	4,682	$54.93	$257,182.26
2/25/2015	Heino Lennartz	Insider	Sell	3,617	$54.82	$198,283.94
2/24/2015	John E Paproski	Insider	Sell	9,282	$52.87	$490,739.34
2/23/2015	Heino Lennartz	Insider	Sell	21,040	$53.40	$1,123,536.00
2/23/2015	Patrick J Zenner	Director	Sell	12,800	$53.69	$687,232.00
11/26/2014	Richard D Luzzi	VP	Sell	8,000	$52.11	$416,880.00
11/21/2014	William J Federici	CFO	Sell	3,000	$51.22	$153,660.00
11/20/2014	Donald E Morel Jr	CEO	Sell	20,000	$51.30	$1,026,000.00
11/13/2014	John R Gailey	VP	Sell	28,000	$52.37	$1,466,360.00
11/11/2014	Michael A Anderson	VP	Sell	4,600	$51.73	$237,958.00
11/10/2014	Warwick Bedwell	Insider	Sell	6,306	$49.95	$314,984.70
8/21/2014	Richard D Luzzi	VP	Sell	10,000	$44.07	$440,700.00
8/20/2014	John R Gailey	VP	Sell	20,000	$43.96	$879,200.00
8/19/2014	Michael A Anderson	VP	Sell	9,800	$43.41	$425,418.00
8/18/2014	William J Federici	CFO	Sell	38,366	$42.56	$1,632,856.96
8/13/2014	Heino Lennartz	Insider	Sell	7,555	$39.65	$299,555.75
8/11/2014	Heino Lennartz	Insider	Sell	11,445	$40.00	$457,800.00
8/7/2014	John E Paproski	Insider	Sell	14,000	$40.44	$566,160.00
5/30/2014	Richard D Luzzi	VP	Sell	22,828	$42.17	$962,656.76
5/29/2014	Heino Lennartz	Insider	Sell	2,000	$43.00	$86,000.00
2/28/2014	Heino Lennartz	Insider	Sell	16,044	$45.84	$735,456.96
2/26/2014	Patrick J Zenner	Director	Sell	12,800	$46.12	$590,336.00
2/24/2014	Warwick Bedwell	Insider	Sell	24,606	$47.49	$1,168,538.94
11/26/2013	Donald E Morel Jr	CEO	Sell	35,000	$48.60	$1,701,000.00
11/22/2013	William J Federici	CFO	Sell	36,000	$48.34	$1,740,240.00
11/19/2013	Karen Flynn	Insider	Sell	5,500	$47.75	$262,625.00
11/8/2013	Michael A Anderson	VP	Sell	9,200	$46.80	$430,560.00
11/7/2013	Heino Lennartz	Insider	Sell	5,102	$46.70	$238,263.40
11/6/2013	Michael A Anderson	VP	Sell	6,000	$46.53	$279,180.00
11/5/2013	John R Gailey	VP	Sell	6,000	$46.83	$280,980.00
11/5/2013	Warwick Bedwell	Insider	Sell	6,304	$46.84	$295,279.36
11/4/2013	Richard D Luzzi	VP	Sell	38,708	$46.99	$1,818,888.92
8/30/2013	Donald E Morel Jr	CEO	Sell	10,000	$74.46	$744,600.00
8/27/2013	John R Gailey	VP	Sell	13,749	$76.77	$1,055,510.73
8/22/2013	L Robert Johnson	Director	Sell	1,883	$76.81	$144,633.23
8/14/2013	John E Paproski	Insider	Sell	6,011	$79.08	$475,349.88
8/12/2013	Anthony Welters	Director	Sell	19,200	$78.43	$1,505,856.00
8/8/2013	Michael A Anderson	VP	Sell	4,300	$78.00	$335,400.00
5/31/2013	Michael A Anderson	VP	Sell	4,000	$68.94	$275,760.00
5/28/2013	Donald E Morel Jr	CEO	Sell	10,000	$67.87	$678,700.00
5/24/2013	L Robert Johnson	Director	Sell	1,700	$67.47	$114,699.00
5/20/2013	John R Gailey	VP	Sell	9,282	$68.54	$636,188.28
5/17/2013	L Robert Johnson	Director	Sell	4,000	$67.80	$271,200.00
5/8/2013	L Robert Johnson	Director	Sell	6,400	$64.49	$412,736.00

(Data available from 1/1/2013 forward)

West Pharmaceutical Services (NYSE WST) News Headlines

Source:

Date	Headline
	West Pharmaceutical Services (WST) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - April 21 at 3:48 AM
	West Pharmaceutical Services (WST) & Female Health (VERU) Head to Head Survey www.americanbankingnews.com - April 19 at 1:22 AM
	Zacks: Analysts Expect West Pharmaceutical Services (WST) Will Post Quarterly Sales of $407.45 Million www.americanbankingnews.com - April 18 at 4:48 AM
	West Pharmaceutical Services (WST) to Release Quarterly Earnings on Wednesday www.americanbankingnews.com - April 18 at 4:02 AM
	EX-Dividend Schedule: Has Raised Dividend for 25 Consecutive Years; Will Trade Ex-Dividend on April 17, 2018 finance.yahoo.com - April 16 at 9:24 AM
	West Pharmaceutical Services (WST) Expected to Announce Earnings of $0.65 Per Share www.americanbankingnews.com - April 16 at 3:24 AM
	Ex-Div Reminder for West Pharmaceutical Services (WST) www.nasdaq.com - April 13 at 4:28 PM
	West to Host First-Quarter 2018 Conference Call finance.yahoo.com - April 12 at 10:23 AM
	Contrasting West Pharmaceutical Services (WST) and Female Health (VERU) www.americanbankingnews.com - April 8 at 11:24 AM
	West Pharmaceutical Services (WST) Cut to "Sell" at ValuEngine www.americanbankingnews.com - April 7 at 7:02 AM
	West Pharmaceutical Services (WST) Rating Lowered to Neutral at Bank of America www.americanbankingnews.com - April 6 at 11:32 PM
	Female Health (VERU) vs. West Pharmaceutical Services (WST) Critical Comparison www.americanbankingnews.com - April 6 at 1:18 PM
	West Pharmaceutical Services Inc. (WST) Expected to Post Quarterly Sales of $409.97 Million www.americanbankingnews.com - April 1 at 4:54 AM
	Brokerages Expect West Pharmaceutical Services Inc. (WST) to Post $0.66 Earnings Per Share www.americanbankingnews.com - March 30 at 5:17 AM
	West Pharmaceutical Services Inc. (WST) Given Average Recommendation of "Hold" by Analysts www.americanbankingnews.com - March 27 at 3:25 AM
	Edited Transcript of WST earnings conference call or presentation 15-Feb-18 2:00pm GMT finance.yahoo.com - March 18 at 9:25 AM
	Short Interest in West Pharmaceutical Services Inc. (WST) Rises By 56.9% www.americanbankingnews.com - March 16 at 1:56 AM
	Gamida Cell Appoints Shai Lankry as Chief Financial Officer www.bizjournals.com - March 15 at 4:54 PM
	Analysts Anticipate West Pharmaceutical Services Inc. (WST) Will Post Quarterly Sales of $409.97 Million www.americanbankingnews.com - March 15 at 1:37 PM
	$0.66 Earnings Per Share Expected for West Pharmaceutical Services Inc. (WST) This Quarter www.americanbankingnews.com - March 13 at 3:18 AM
	Brokers Offer Predictions for West Pharmaceutical Services Inc.'s Q1 2018 Earnings (WST) www.americanbankingnews.com - March 12 at 1:17 AM
	Is West Pharmaceutical Services Inc (NYSE:WST) A Sell At Its Current PE Ratio? finance.yahoo.com - March 9 at 5:26 PM
	WINTON GROUP Ltd Buys New Stake in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - March 6 at 3:38 PM
	West Pharmaceutical Services Inc. (WST) Stake Increased by Koch Industries Inc. www.americanbankingnews.com - March 6 at 2:03 PM
	West Pharmaceutical Services Inc. (WST) Position Increased by Alliancebernstein L.P. www.americanbankingnews.com - March 6 at 4:14 AM
	West Pharmaceutical Services Inc. (WST) Shares Sold by Lombard Odier Asset Management Switzerland SA www.americanbankingnews.com - March 4 at 2:39 PM
	State of Tennessee Treasury Department Sells 40,000 Shares of West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - March 4 at 11:46 AM
	Bank of New York Mellon Corp Has $85.22 Million Holdings in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - March 3 at 4:43 AM
	BRIEF-West Chief Financial Officer William Federici Announces Plans To Retire www.reuters.com - March 2 at 9:23 AM
	William Federici announces plans to retire seekingalpha.com - March 2 at 9:23 AM
	First Trust Advisors LP Trims Stake in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - March 2 at 8:18 AM
	West Pharmaceutical Services Inc. (WST) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - March 2 at 3:36 AM
	The Manufacturers Life Insurance Company Has $12.16 Million Stake in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - March 1 at 6:04 PM
	West Pharmaceutical Services Inc (WST) Files 10-K for the Fiscal Year Ended on December 31, 2017 finance.yahoo.com - February 27 at 9:31 AM
	Carillon Tower Advisers Inc. Invests $39.04 Million in West Pharmaceutical Services Inc. (WST) Stock www.americanbankingnews.com - February 27 at 5:28 AM
	West Pharmaceutical Services Inc. (WST) Shares Bought by BlackRock Inc. www.americanbankingnews.com - February 27 at 4:57 AM
	Rhumbline Advisers Has $17.01 Million Position in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - February 26 at 1:42 PM
	West Pharmaceutical Services Inc. (WST) Expected to Post Quarterly Sales of $412.97 Million www.americanbankingnews.com - February 26 at 10:18 AM
	West Pharmaceutical Services Inc. (WST) Holdings Trimmed by Wells Fargo & Company MN www.americanbankingnews.com - February 26 at 10:10 AM
	Brown Advisory Inc. Buys 124,227 Shares of West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - February 26 at 4:52 AM
	West Pharmaceutical Services Inc. (WST) Shares Sold by Employees Retirement System of Texas www.americanbankingnews.com - February 25 at 5:26 AM
	Eaton Vance Management Cuts Stake in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - February 25 at 5:20 AM
	Citadel Advisors LLC Has $3.23 Million Position in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - February 25 at 4:56 AM
	Arizona State Retirement System Has $5.27 Million Holdings in West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - February 25 at 4:16 AM
	West Pharmaceutical (WST) Presents At RBC Capital Markets Global Healthcare Conference - Slideshow seekingalpha.com - February 24 at 9:16 AM
	California Public Employees Retirement System Acquires 4,713 Shares of West Pharmaceutical Services Inc. (WST) www.americanbankingnews.com - February 24 at 5:10 AM
	Q1 2018 EPS Estimates for West Pharmaceutical Services Inc. (WST) Lowered by Jefferies Group www.americanbankingnews.com - February 19 at 1:24 AM
	West Pharmaceutical Services Inc. Declares Quarterly Dividend of $0.14 (WST) www.americanbankingnews.com - February 16 at 8:02 PM
	West Pharmaceutical Services Inc. 2017 Q4 - Results - Earnings Call Slides seekingalpha.com - February 15 at 4:33 PM
	West Pharmaceutical Services (WST) to Repurchase 800,000 Outstanding Stock www.americanbankingnews.com - February 15 at 11:16 AM

West Pharmaceutical Services (NYSE:WST) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

West Pharmaceutical Services (NYSE:WST) Income Statement, Balance Sheet and Cash Flow Statement

West Pharmaceutical Services (NYSE WST) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff